ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Juan C Chachques
Pantelis G Argyriadis
Robert A Frank
Jean-N.oël Fabiani
Alain F Carpentier
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chachques, J. C.
Right arrow Articles by Carpentier, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chachques, J. C.
Right arrow Articles by Carpentier, A. F.

Ann Thorac Surg 2003;75:1464-1468
© 2003 The Society of Thoracic Surgeons


Original article: cardiovascular

Right ventricular cardiomyoplasty: 10-year follow-up

Juan C Chachques, MD, PhD*,a, Pantelis G Argyriadis, MDa, Guy Fontaine, MD, PhDa, Jean-Louis Hebert, MDa, Robert A Frank, MDa, Nicola D’Attellis, MDa, Jean-N.oël Fabiani, MDa, Alain F Carpentier, MD, PhDa

a Department of Cardiovascular Surgery, Pompidou and Broussais Hospitals, Paris, France

Accepted for publication November 12, 2002.

* Address reprint requests to Dr Chachques, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France (Email: j.chachques{at}brs.ap-hop-paris.fr).

Background: Chronically depressed right ventricular (RV) function presents an unsolved therapeutic challenge in cardiac surgery. Despite recent advances in medical and surgical therapies, prognosis remains poor and patient’s quality of life and mortality are frequently unacceptable. The aim of this study is to present the first clinical report and long-term results of RV dynamic cardiomyoplasty applied in patients with RV failure caused by isolated RV cardiomyopathies.

Methods: Seven consecutive patients (5 males, 2 females; mean age, 40 ± 9 years; range, 15 to 63 years) from a series of 113 cardiomyoplasty procedures performed at Broussais and Pompidou Hospitals were evaluated. The mean duration of follow-up was 10 ± 3.5 years. All patients had predominant RV dysfunction, associated with tricuspid regurgitation in 6 patients. The cause of RV failure was arrhythmogenic cardiomyopathy (4 patients), ischemic (2 patients), and Uhl’s disease (1 patient), and endomyocardial fibrosis (1 patient). Six patients were in preoperative New York Heart Association functional class III and 1 was in intermittent class III/IV. The mean preoperative ejection fraction (measured by isotopic technique) was 18% ± 5.7% for the right ventricle and 40% ± 13% for the left ventricle. Right ventricular dynamic cardiomyoplasty consists of wrapping the RV free walls with the left latissimus dorsi muscle flap. The distal part of the latissimus dorsi muscle is fixed to the diaphragm and then electrostimulated. Six patients required associated tricuspid valve surgery.

Results: There were no perioperative deaths. The mean duration of follow-up was 10 ± 3.5 years. Six patients are alive with a remarkable quality of life, 4 are in New York Heart Association functional class I and 2 are in class II. One patient who was in New York Heart Association functional class II died in postoperative year 7 caused by stroke. At last follow-up, mean RV ejection fraction was 33% ± 11.8% and left ventricular ejection fraction was 52% ± 12.6%.

Conclusions: The results of this long-term study demonstrate hemodynamic and functional improvements after RV cardiomyoplasty without perioperative mortality, no long-term malignant arrhythmias, and RV dysfunction related deaths. We believe that RV cardiomyoplasty, associated with tricuspid valve surgery when required, could be an effective treatment for severe RV failure.




This article has been cited by other articles:


Home page
Eur Heart JHome page
G. H. Fontaine
The multiple facets of right ventricular cardiomyopathies
Eur. Heart J., May 1, 2011; 32(9): 1049 - 1051.
[Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
J. C Chachques, O. Jegaden, T. Mesana, Y. Glock, P. A Grandjean, and A. F Carpentier
Cardiac Bioassist: Results of the French Multicenter Cardiomyoplasty Study
Asian Cardiovasc Thorac Ann, December 1, 2009; 17(6): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Nour, G. Wu, Z. Zhensheng, J. C Chachques, A. Carpentier, and D. Payen
The Forgotten Driving Forces in Right Heart Failure: New Concept and Device*
Asian Cardiovasc Thorac Ann, October 1, 2009; 17(5): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
J. C. Chachques
Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure?
Eur J Cardiothorac Surg, February 1, 2009; 35(2): 201 - 203.
[Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
J. C. Chachques, O. J. Jegaden, V. Bors, T. Mesana, C. Latremouille, P. A. Grandjean, J. N. Fabiani, and A. Carpentier
Heart transplantation following cardiomyoplasty: a biological bridge
Eur J Cardiothorac Surg, April 1, 2008; 33(4): 685 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.